Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

66.67 USD +0.90 (+1.37%)
Streaming Delayed Price Updated: 9:52 AM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,031,166
Open 66.02
Bid (Size) 66.66 (2)
Ask (Size) 66.67 (1)
Prev. Close 65.77
Today's Range 65.86 - 66.78
52wk Range 56.56 - 85.79
Shares Outstanding N/A
Dividend Yield 4.26%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Gilead Sciences to Release First Quarter 2021 Financial Results on Thursday, April 29, 2021
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2021 financial results will be released on Thursday, April 29, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s... 
From Business Wire News Releases
Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer
Almost 1/3 of Patients in Pivotal TROPHY Study Responded to Treatment 
From PR Newswire

Performance

YTD
+10.91%
+10.91%
1 Month
+4.16%
+4.16%
3 Month
+6.84%
+6.84%
6 Month
+5.89%
+5.89%
1 Year
-10.67%
-10.67%

More News

Read More
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer
From Business Wire News Releases
Everest Medicines Announces that Licensing Partner Gilead Sciences, Inc. has Received Full US FDA Approval of Trodelvy® for the Treatment of Previously Treated Unresectable Locally Advanced or Metasta
From PR Newswire
Pharma Companies Seeking to Improve Health Outcomes With Innovative Products
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Pharma Companies Seeking to Improve Health Outcomes With Innovative Products
From PR Newswire
IBB, AMGN, GILD, ILMN: Large Outflows Detected at ETF
Tags ETFs
From ETF Channel
Cancer Biotech Tango Therapeutics Picks Boxer Capital's SPAC To Go Public Via $353M Merger
Tags Benzinga M&A Contracts
From Benzinga
3 Top Healthcare Stocks to Buy Right Now
Tags JNJ Market News GILD
From Motley Fool
A Peek Into The Markets: US Stock Futures Edge Higher; Bank Earnings In Focus
Tags Eurozone A Peek Into The Markets Earnings
From Benzinga
Drugmakers Are Vying for a Multibillion-Dollar Market
Tags PFE GILD INCY
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.